Efficacy and safety of early target-controlled plasma volume replacement with a balanced gelatine solution versus a balanced electrolyte solution in patients with severe sepsis/septic shock: study protocol, design, and rationale of a prospective, randomized, controlled, double-blind, multicentric, international clinical trial: GENIUS—Gelatine use in ICU and sepsis

doi:10.1186/s13063-021-05311-8

Efficacy and safety of early target-controlled plasma volume replacement with a balanced gelatine solution versus a balanced electrolyte solution in patients with severe sepsis/septic shock: study protocol, design, and rationale of a prospective, randomized, controlled, double-blind, multicentric, international clinical trial: GENIUS—Gelatine use in ICU and sepsis

Research output: Contribution to journal › Article › peer-review

Original language	English
Article number	376
Journal	Trials
Volume	22
Issue number	1
DOIs	https://doi.org/10.1186/s13063-021-05311-8
Publication status	Published - Dec 2021
Externally published	Yes

ASJC Scopus Subject Areas

Pharmacology (medical)
Medicine (miscellaneous)

Keywords

Capillary leakage
Colloids
Critically ill
Fluid management
Gelatine
Resuscitation
Sepsis

Access to Document

10.1186/s13063-021-05311-8

Fingerprint

Dive into the research topics of 'Efficacy and safety of early target-controlled plasma volume replacement with a balanced gelatine solution versus a balanced electrolyte solution in patients with severe sepsis/septic shock: study protocol, design, and rationale of a prospective, randomized, controlled, double-blind, multicentric, international clinical trial: GENIUS—Gelatine use in ICU and sepsis'. Together they form a unique fingerprint.

Cite this

(2021). Efficacy and safety of early target-controlled plasma volume replacement with a balanced gelatine solution versus a balanced electrolyte solution in patients with severe sepsis/septic shock: study protocol, design, and rationale of a prospective, randomized, controlled, double-blind, multicentric, international clinical trial: GENIUS—Gelatine use in ICU and sepsis. Trials, 22(1), Article 376. https://doi.org/10.1186/s13063-021-05311-8

Efficacy and safety of early target-controlled plasma volume replacement with a balanced gelatine solution versus a balanced electrolyte solution in patients with severe sepsis/septic shock: study protocol, design, and rationale of a prospective, randomized, controlled, double-blind, multicentric, international clinical trial: GENIUS—Gelatine use in ICU and sepsis.
In: Trials, Vol. 22, No. 1, 376, 12.2021.

Research output: Contribution to journal › Article › peer-review

2021, 'Efficacy and safety of early target-controlled plasma volume replacement with a balanced gelatine solution versus a balanced electrolyte solution in patients with severe sepsis/septic shock: study protocol, design, and rationale of a prospective, randomized, controlled, double-blind, multicentric, international clinical trial: GENIUS—Gelatine use in ICU and sepsis', Trials, vol. 22, no. 1, 376. https://doi.org/10.1186/s13063-021-05311-8

Efficacy and safety of early target-controlled plasma volume replacement with a balanced gelatine solution versus a balanced electrolyte solution in patients with severe sepsis/septic shock: study protocol, design, and rationale of a prospective, randomized, controlled, double-blind, multicentric, international clinical trial: GENIUS—Gelatine use in ICU and sepsis. Trials. 2021 Dec;22(1):376. doi: 10.1186/s13063-021-05311-8

/ Efficacy and safety of early target-controlled plasma volume replacement with a balanced gelatine solution versus a balanced electrolyte solution in patients with severe sepsis/septic shock : study protocol, design, and rationale of a prospective, randomized, controlled, double-blind, multicentric, international clinical trial: GENIUS—Gelatine use in ICU and sepsis. In: Trials. 2021 ; Vol. 22, No. 1.

@article{103a0cd5338a4aceb1adadb1c93c232f,

title = "Efficacy and safety of early target-controlled plasma volume replacement with a balanced gelatine solution versus a balanced electrolyte solution in patients with severe sepsis/septic shock: study protocol, design, and rationale of a prospective, randomized, controlled, double-blind, multicentric, international clinical trial: GENIUS—Gelatine use in ICU and sepsis",

keywords = "Capillary leakage, Colloids, Critically ill, Fluid management, Gelatine, Resuscitation, Sepsis",

note = "Publisher Copyright: {\textcopyright} 2021, The Author(s).",

year = "2021",

month = dec,

doi = "10.1186/s13063-021-05311-8",

language = "English",

volume = "22",

journal = "Trials",

issn = "1745-6215",

publisher = "BioMed Central",

number = "1",

}

TY - JOUR

T1 - Efficacy and safety of early target-controlled plasma volume replacement with a balanced gelatine solution versus a balanced electrolyte solution in patients with severe sepsis/septic shock

T2 - study protocol, design, and rationale of a prospective, randomized, controlled, double-blind, multicentric, international clinical trial: GENIUS—Gelatine use in ICU and sepsis

PY - 2021/12

Y1 - 2021/12

KW - Capillary leakage

KW - Colloids

KW - Critically ill

KW - Fluid management

KW - Gelatine

KW - Resuscitation

KW - Sepsis

UR - http://www.scopus.com/inward/record.url?scp=85107139824&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85107139824&partnerID=8YFLogxK

U2 - 10.1186/s13063-021-05311-8

DO - 10.1186/s13063-021-05311-8

M3 - Article

C2 - 34078421

AN - SCOPUS:85107139824

SN - 1745-6215

VL - 22

JO - Trials

JF - Trials

IS - 1

M1 - 376

ER -

ASJC Scopus Subject Areas

Keywords

Access to Document

Other files and links

Fingerprint

Cite this